Cover Image
市場調查報告書

醫藥品產業:全球產業年鑑

Pharmaceuticals: Global Industry Almanac 2016

出版商 MarketLine 商品編碼 169426
出版日期 內容資訊 英文 477 Pages
訂單完成後即時交付
價格
Back to Top
醫藥品產業:全球產業年鑑 Pharmaceuticals: Global Industry Almanac 2016
出版日期: 2016年10月19日 內容資訊: 英文 477 Pages
簡介

本報告提供全球醫藥品產業相關,不同地區,各國家市場的規模,區分,預測,主要企業等,為您概述為以下內容。

第1章 介紹

第2章 全球醫藥品產業

  • 市場概要
  • 市場銷售額
  • 市場市場區隔I
  • 市場市場區隔II
  • 市場佔有率
  • 波特的五力分析
  • 主要企業
  • 市場預測

第3章 亞太地區的醫藥品產業

  • 市場概要
  • 市場銷售額
  • 市場市場區隔I
  • 市場市場區隔II
  • 市場佔有率
  • 波特的五力分析
  • 主要企業
  • 市場預測

第4章 歐洲的醫藥品產業

  • 市場概要
  • 市場銷售額
  • 市場市場區隔I
  • 市場市場區隔II
  • 市場佔有率
  • 波特的五力分析
  • 主要企業
  • 市場預測
  • 宏觀經濟指標

第5章 澳洲

第6章 比利時

第7章 巴西

第8章 加拿大

第9章 中國

第10章 捷克共和國

第11章 丹麥

第12章 法國

第13章 德國

第14章 匈牙利

第15章 印度

第16章 義大利

第17章 日本

第18章 墨西哥

第19章 荷蘭

第20章 挪威

第21章 波蘭

第22章 俄羅斯

第23章 新加坡

第24章 南非

第25章 韓國

第26章 西班牙

第27章 瑞典

第28章 英國

第29章 美國

第30章 附錄

圖表名單

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MLIG16035-01

Summary

Global Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Findings

  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the global pharmaceuticals market
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global pharmaceuticals market
  • Leading company profiles reveal details of key pharmaceuticals market players' global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the global pharmaceuticals market with five year forecasts

Synopsis

Essential resource for top-line data and analysis covering the global pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends and leading companies.

Reasons To Buy

  • What was the size of the global pharmaceuticals market by value in 2015?
  • What will be the size of the global pharmaceuticals market in 2020?
  • What factors are affecting the strength of competition in the global pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitors in the global pharmaceuticals market?

Key Highlights

  • The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2015 annual average exchange rates.
  • The global pharmaceuticals market had total revenues of $951.4bn in 2015, representing a compound annual growth rate (CAGR) of 4.6% between 2011 and 2015.
  • The US, Japan and China are the very largest markets followed by the four biggest European markets.
  • The performance of the market is forecast to accelerate, with an anticipated CAGR of 5% for the five-year period 2015 - 2020, which is expected to drive the market to a value of $1,213.2bn by the end of 2020.

Table of Contents

EXECUTIVE SUMMARY

  • Market value
  • Market value forecast
  • Geography segmentation
  • Market share

Introduction

  • What is this report about?
  • Who is the target reader?
  • How to use this report
  • Definitions

Global Pharmaceuticals

  • Market Overview
  • Market Data
  • Market Segmentation
  • Market outlook
  • Five forces analysis

Pharmaceuticals in Asia-Pacific

  • Market Overview
  • Market Data
  • Market Segmentation
  • Market outlook
  • Five forces analysis

Pharmaceuticals in Europe

  • Market Overview
  • Market Data
  • Market Segmentation
  • Market outlook
  • Five forces analysis

Pharmaceuticals in France

  • Market Overview
  • Market Data
  • Market Segmentation
  • Market outlook
  • Five forces analysis
  • Macroeconomic indicators

Pharmaceuticals in Germany

  • Market Overview
  • Market Data
  • Market Segmentation
  • Market outlook
  • Five forces analysis
  • Macroeconomic indicators

Pharmaceuticals in Australia

  • Market Overview
  • Market Data
  • Market Segmentation
  • Market outlook
  • Five forces analysis
  • Macroeconomic indicators

Pharmaceuticals in Brazil

  • Market Overview
  • Market Data
  • Market Segmentation
  • Market outlook
  • Five forces analysis
  • Macroeconomic indicators

Pharmaceuticals in Canada

  • Market Overview
  • Market Data
  • Market Segmentation
  • Market outlook
  • Five forces analysis
  • Macroeconomic indicators

Pharmaceuticals in China

  • Market Overview
  • Market Data
  • Market Segmentation
  • Market outlook
  • Five forces analysis
  • Macroeconomic indicators

Pharmaceuticals in India

  • Market Overview
  • Market Data
  • Market Segmentation
  • Market outlook
  • Five forces analysis
  • Macroeconomic indicators

Pharmaceuticals in Indonesia

  • Market Overview
  • Market Data
  • Market Segmentation
  • Market outlook
  • Five forces analysis
  • Macroeconomic indicators

Pharmaceuticals in Italy

  • Market Overview
  • Market Data
  • Market Segmentation
  • Market outlook
  • Five forces analysis
  • Macroeconomic indicators

Pharmaceuticals in Japan

  • Market Overview
  • Market Data
  • Market Segmentation
  • Market outlook
  • Five forces analysis
  • Macroeconomic indicators

Pharmaceuticals in Mexico

  • Market Overview
  • Market Data
  • Market Segmentation
  • Market outlook
  • Five forces analysis
  • Macroeconomic indicators

Pharmaceuticals in The Netherlands

  • Market Overview
  • Market Data
  • Market Segmentation
  • Market outlook
  • Five forces analysis
  • Macroeconomic indicators

Pharmaceuticals in North America

  • Market Overview
  • Market Data
  • Market Segmentation
  • Market outlook
  • Five forces analysis

Pharmaceuticals in Russia

  • Market Overview
  • Market Data
  • Market Segmentation
  • Market outlook
  • Five forces analysis
  • Macroeconomic indicators

Pharmaceuticals in Scandinavia

  • Market Overview
  • Market Data
  • Market Segmentation
  • Market outlook
  • Five forces analysis

Pharmaceuticals in Singapore

  • Market Overview
  • Market Data
  • Market Segmentation
  • Market outlook
  • Five forces analysis
  • Macroeconomic indicators

Pharmaceuticals in South Africa

  • Market Overview
  • Market Data
  • Market Segmentation
  • Market outlook
  • Five forces analysis
  • Macroeconomic indicators

Pharmaceuticals in South Korea

  • Market Overview
  • Market Data
  • Market Segmentation
  • Market outlook
  • Five forces analysis
  • Macroeconomic indicators

Pharmaceuticals in Spain

  • Market Overview
  • Market Data
  • Market Segmentation
  • Market outlook
  • Five forces analysis
  • Macroeconomic indicators

Pharmaceuticals in Turkey

  • Market Overview
  • Market Data
  • Market Segmentation
  • Market outlook
  • Five forces analysis
  • Macroeconomic indicators

Pharmaceuticals in The United Kingdom

  • Market Overview
  • Market Data
  • Market Segmentation
  • Market outlook
  • Five forces analysis
  • Macroeconomic indicators

Pharmaceuticals in The United States

  • Market Overview
  • Market Data
  • Market Segmentation
  • Market outlook
  • Five forces analysis
  • Macroeconomic indicators
  • Company Profiles
  • Leading companies

Appendix

  • Methodology
  • About MarketLine

List of Tables

  • Table 1: Global pharmaceuticals market value: $ billion, 2011-15
  • Table 2: Global pharmaceuticals market geography segmentation: $ billion, 2015
  • Table 3: Global pharmaceuticals market share: % share, by value, 2015
  • Table 4: Global pharmaceuticals market value forecast: $ billion, 2015-20
  • Table 5: Asia-Pacific pharmaceuticals market value: $ billion, 2011-15
  • Table 6: Asia-Pacific pharmaceuticals market geography segmentation: $ billion, 2015
  • Table 7: Asia-Pacific pharmaceuticals market share: % share, by value, 2015
  • Table 8: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2015-20
  • Table 9: Europe pharmaceuticals market value: $ billion, 2011-15
  • Table 10: Europe pharmaceuticals market geography segmentation: $ billion, 2015
  • Table 11: Europe pharmaceuticals market share: % share, by value, 2015
  • Table 12: Europe pharmaceuticals market value forecast: $ billion, 2015-20
  • Table 13: France pharmaceuticals market value: $ billion, 2011-15
  • Table 14: France pharmaceuticals market geography segmentation: $ billion, 2015
  • Table 15: France pharmaceuticals market share: % share, by value, 2015
  • Table 16: France pharmaceuticals market value forecast: $ billion, 2015-20
  • Table 17: France size of population (million), 2011-15
  • Table 18: France gdp (constant 2005 prices, $ billion), 2011-15
  • Table 19: France gdp (current prices, $ billion), 2011-15
  • Table 20: France inflation, 2011-15
  • Table 21: France consumer price index (absolute), 2011-15
  • Table 22: France exchange rate, 2011-15
  • Table 23: Germany pharmaceuticals market value: $ billion, 2011-15
  • Table 24: Germany pharmaceuticals market geography segmentation: $ billion, 2015
  • Table 25: Germany pharmaceuticals market share: % share, by value, 2015
  • Table 26: Germany pharmaceuticals market value forecast: $ billion, 2015-20
  • Table 27: Germany size of population (million), 2011-15
  • Table 28: Germany gdp (constant 2005 prices, $ billion), 2011-15
  • Table 29: Germany gdp (current prices, $ billion), 2011-15
  • Table 30: Germany inflation, 2011-15
  • Table 31: Germany consumer price index (absolute), 2011-15
  • Table 32: Germany exchange rate, 2011-15
  • Table 33: Australia pharmaceuticals market value: $ billion, 2011-15
  • Table 34: Australia pharmaceuticals market geography segmentation: $ billion, 2015
  • Table 35: Australia pharmaceuticals market share: % share, by value, 2015
  • Table 36: Australia pharmaceuticals market value forecast: $ billion, 2015-20
  • Table 37: Australia size of population (million), 2011-15
  • Table 38: Australia gdp (constant 2005 prices, $ billion), 2011-15
  • Table 39: Australia gdp (current prices, $ billion), 2011-15
  • Table 40: Australia inflation, 2011-15
  • Table 41: Australia consumer price index (absolute), 2011-15
  • Table 42: Australia exchange rate, 2011-15
  • Table 43: Brazil pharmaceuticals market value: $ billion, 2011-15
  • Table 44: Brazil pharmaceuticals market geography segmentation: $ billion, 2015
  • Table 45: Brazil pharmaceuticals market share: % share, by value, 2015
  • Table 46: Brazil pharmaceuticals market value forecast: $ billion, 2015-20
  • Table 47: Brazil size of population (million), 2011-15
  • Table 48: Brazil gdp (constant 2005 prices, $ billion), 2011-15
  • Table 49: Brazil gdp (current prices, $ billion), 2011-15
  • Table 50: Brazil inflation, 2011-15
  • Table 51: Brazil consumer price index (absolute), 2011-15
  • Table 52: Brazil exchange rate, 2011-15
  • Table 53: Canada pharmaceuticals market value: $ billion, 2011-15
  • Table 54: Canada pharmaceuticals market geography segmentation: $ billion, 2015
  • Table 55: Canada pharmaceuticals market share: % share, by value, 2015
  • Table 56: Canada pharmaceuticals market value forecast: $ billion, 2015-20
  • Table 57: Canada size of population (million), 2011-15
  • Table 58: Canada gdp (constant 2005 prices, $ billion), 2011-15
  • Table 59: Canada gdp (current prices, $ billion), 2011-15
  • Table 60: Canada inflation, 2011-15
  • Table 61: Canada consumer price index (absolute), 2011-15
  • Table 62: Canada exchange rate, 2011-15
  • Table 63: China pharmaceuticals market value: $ billion, 2011-15
  • Table 64: China pharmaceuticals market geography segmentation: $ billion, 2015
  • Table 65: China pharmaceuticals market share: % share, by value, 2015
  • Table 66: China pharmaceuticals market value forecast: $ billion, 2015-20
  • Table 67: China size of population (million), 2011-15
  • Table 68: China gdp (constant 2005 prices, $ billion), 2011-15
  • Table 69: China gdp (current prices, $ billion), 2011-15
  • Table 70: China inflation, 2011-15
  • Table 71: China consumer price index (absolute), 2011-15
  • Table 72: China exchange rate, 2011-15
  • Table 73: India pharmaceuticals market value: $ billion, 2011-15
  • Table 74: India pharmaceuticals market geography segmentation: $ billion, 2015
  • Table 75: India pharmaceuticals market share: % share, by value, 2015
  • Table 76: India pharmaceuticals market value forecast: $ billion, 2015-20
  • Table 77: India size of population (million), 2011-15
  • Table 78: India gdp (constant 2005 prices, $ billion), 2011-15
  • Table 79: India gdp (current prices, $ billion), 2011-15
  • Table 80: India inflation, 2011-15
  • Table 81: India consumer price index (absolute), 2011-15
  • Table 82: India exchange rate, 2011-15
  • Table 83: Indonesia pharmaceuticals market value: $ billion, 2011-15
  • Table 84: Indonesia pharmaceuticals market geography segmentation: $ billion, 2015
  • Table 85: Indonesia pharmaceuticals market share: % share, by value, 2015
  • Table 86: Indonesia pharmaceuticals market value forecast: $ billion, 2015-20
  • Table 87: Indonesia size of population (million), 2011-15
  • Table 88: Indonesia gdp (constant 2005 prices, $ billion), 2011-15
  • Table 89: Indonesia gdp (current prices, $ billion), 2011-15
  • Table 90: Indonesia inflation, 2011-15
  • Table 91: Indonesia consumer price index (absolute), 2011-15
  • Table 92: Indonesia exchange rate, 2011-15
  • Table 93: Italy pharmaceuticals market value: $ billion, 2011-15
  • Table 94: Italy pharmaceuticals market geography segmentation: $ billion, 2015
  • Table 95: Italy pharmaceuticals market share: % share, by value, 2015
  • Table 96: Italy pharmaceuticals market value forecast: $ billion, 2015-20
  • Table 97: Italy size of population (million), 2011-15
  • Table 98: Italy gdp (constant 2005 prices, $ billion), 2011-15
  • Table 99: Italy gdp (current prices, $ billion), 2011-15
  • Table 100: Italy inflation, 2011-15
  • Table 101: Italy consumer price index (absolute), 2011-15
  • Table 102: Italy exchange rate, 2011-15
  • Table 103: Japan pharmaceuticals market value: $ billion, 2011-15
  • Table 104: Japan pharmaceuticals market geography segmentation: $ billion, 2015
  • Table 105: Japan pharmaceuticals market share: % share, by value, 2015
  • Table 106: Japan pharmaceuticals market value forecast: $ billion, 2015-20
  • Table 107: Japan size of population (million), 2011-15
  • Table 108: Japan gdp (constant 2005 prices, $ billion), 2011-15
  • Table 109: Japan gdp (current prices, $ billion), 2011-15
  • Table 110: Japan inflation, 2011-15
  • Table 111: Japan consumer price index (absolute), 2011-15
  • Table 112: Japan exchange rate, 2011-15
  • Table 113: Mexico pharmaceuticals market value: $ billion, 2011-15
  • Table 114: Mexico pharmaceuticals market geography segmentation: $ billion, 2015
  • Table 115: Mexico pharmaceuticals market share: % share, by value, 2015
  • Table 116: Mexico pharmaceuticals market value forecast: $ billion, 2015-20
  • Table 117: Mexico size of population (million), 2011-15
  • Table 118: Mexico gdp (constant 2005 prices, $ billion), 2011-15
  • Table 119: Mexico gdp (current prices, $ billion), 2011-15
  • Table 120: Mexico inflation, 2011-15
  • Table 121: Mexico consumer price index (absolute), 2011-15
  • Table 122: Mexico exchange rate, 2011-15
  • Table 123: Netherlands pharmaceuticals market value: $ billion, 2011-15
  • Table 124: Netherlands pharmaceuticals market geography segmentation: $ billion, 2015
  • Table 125: Netherlands pharmaceuticals market share: % share, by value, 2015
  • Table 126: Netherlands pharmaceuticals market value forecast: $ billion, 2015-20
  • Table 127: Netherlands size of population (million), 2011-15
  • Table 128: Netherlands gdp (constant 2005 prices, $ billion), 2011-15
  • Table 129: Netherlands gdp (current prices, $ billion), 2011-15
  • Table 130: Netherlands inflation, 2011-15
  • Table 131: Netherlands consumer price index (absolute), 2011-15
  • Table 132: Netherlands exchange rate, 2011-15
  • Table 133: North America pharmaceuticals market value: $ billion, 2011-15
  • Table 134: North America pharmaceuticals market geography segmentation: $ billion, 2015
  • Table 135: North America pharmaceuticals market share: % share, by value, 2015
  • Table 136: North America pharmaceuticals market value forecast: $ billion, 2015-20
  • Table 137: Russia pharmaceuticals market value: $ billion, 2011-15
  • Table 138: Russia pharmaceuticals market geography segmentation: $ billion, 2015
  • Table 139: Russia pharmaceuticals market share: % share, by value, 2015
  • Table 140: Russia pharmaceuticals market value forecast: $ billion, 2015-20
  • Table 141: Russia size of population (million), 2011-15
  • Table 142: Russia gdp (constant 2005 prices, $ billion), 2011-15
  • Table 143: Russia gdp (current prices, $ billion), 2011-15
  • Table 144: Russia inflation, 2011-15
  • Table 145: Russia consumer price index (absolute), 2011-15
  • Table 146: Russia exchange rate, 2011-15
  • Table 147: Scandinavia pharmaceuticals market value: $ billion, 2011-15
  • Table 148: Scandinavia pharmaceuticals market geography segmentation: $ billion, 2015
  • Table 149: Scandinavia pharmaceuticals market share: % share, by value, 2015
  • Table 150: Scandinavia pharmaceuticals market value forecast: $ billion, 2015-20
  • Table 151: Singapore pharmaceuticals market value: $ billion, 2011-15
  • Table 152: Singapore pharmaceuticals market geography segmentation: $ billion, 2015
  • Table 153: Singapore pharmaceuticals market share: % share, by value, 2015
  • Table 154: Singapore pharmaceuticals market value forecast: $ billion, 2015-20
  • Table 155: Singapore size of population (million), 2011-15
  • Table 156: Singapore gdp (constant 2005 prices, $ billion), 2011-15
  • Table 157: Singapore gdp (current prices, $ billion), 2011-15
  • Table 158: Singapore inflation, 2011-15
  • Table 159: Singapore consumer price index (absolute), 2011-15
  • Table 160: Singapore exchange rate, 2011-15
  • Table 161: South Africa pharmaceuticals market value: $ billion, 2011-15
  • Table 162: South Africa pharmaceuticals market geography segmentation: $ billion, 2015
  • Table 163: South Africa pharmaceuticals market share: % share, by value, 2015
  • Table 164: South Africa pharmaceuticals market value forecast: $ billion, 2015-20
  • Table 165: South Africa size of population (million), 2011-15
  • Table 166: South Africa gdp (constant 2005 prices, $ billion), 2011-15
  • Table 167: South Africa gdp (current prices, $ billion), 2011-15
  • Table 168: South Africa inflation, 2011-15
  • Table 169: South Africa consumer price index (absolute), 2011-15
  • Table 170: South Africa exchange rate, 2011-15
  • Table 171: South Korea pharmaceuticals market value: $ billion, 2011-15
  • Table 172: South Korea pharmaceuticals market geography segmentation: $ billion, 2015
  • Table 173: South Korea pharmaceuticals market share: % share, by value, 2015
  • Table 174: South Korea pharmaceuticals market value forecast: $ billion, 2015-20
  • Table 175: South Korea size of population (million), 2011-15
  • Table 176: South Korea gdp (constant 2005 prices, $ billion), 2011-15
  • Table 177: South Korea gdp (current prices, $ billion), 2011-15
  • Table 178: South Korea inflation, 2011-15
  • Table 179: South Korea consumer price index (absolute), 2011-15
  • Table 180: South Korea exchange rate, 2011-15
  • Table 181: Spain pharmaceuticals market value: $ billion, 2011-15
  • Table 182: Spain pharmaceuticals market geography segmentation: $ billion, 2015
  • Table 183: Spain pharmaceuticals market share: % share, by value, 2015
  • Table 184: Spain pharmaceuticals market value forecast: $ billion, 2015-20
  • Table 185: Spain size of population (million), 2011-15
  • Table 186: Spain gdp (constant 2005 prices, $ billion), 2011-15
  • Table 187: Spain gdp (current prices, $ billion), 2011-15
  • Table 188: Spain inflation, 2011-15
  • Table 189: Spain consumer price index (absolute), 2011-15
  • Table 190: Spain exchange rate, 2011-15
  • Table 191: Turkey pharmaceuticals market value: $ billion, 2011-15
  • Table 192: Turkey pharmaceuticals market geography segmentation: $ billion, 2015
  • Table 193: Turkey pharmaceuticals market share: % share, by value, 2015
  • Table 194: Turkey pharmaceuticals market value forecast: $ billion, 2015-20
  • Table 195: Turkey size of population (million), 2011-15
  • Table 196: Turkey gdp (constant 2005 prices, $ billion), 2011-15
  • Table 197: Turkey gdp (current prices, $ billion), 2011-15
  • Table 198: Turkey inflation, 2011-15
  • Table 199: Turkey consumer price index (absolute), 2011-15
  • Table 200: Turkey exchange rate, 2011-15
  • Table 201: United Kingdom pharmaceuticals market value: $ billion, 2011-15
  • Table 202: United Kingdom pharmaceuticals market geography segmentation: $ billion, 2015
  • Table 203: United Kingdom pharmaceuticals market share: % share, by value, 2015
  • Table 204: United Kingdom pharmaceuticals market value forecast: $ billion, 2015-20
  • Table 205: United Kingdom size of population (million), 2011-15
  • Table 206: United Kingdom gdp (constant 2005 prices, $ billion), 2011-15
  • Table 207: United Kingdom gdp (current prices, $ billion), 2011-15
  • Table 208: United Kingdom inflation, 2011-15
  • Table 209: United Kingdom consumer price index (absolute), 2011-15
  • Table 210: United Kingdom exchange rate, 2011-15
  • Table 211: United States pharmaceuticals market value: $ billion, 2011-15
  • Table 212: United States pharmaceuticals market geography segmentation: $ billion, 2015
  • Table 213: United States pharmaceuticals market share: % share, by value, 2015
  • Table 214: United States pharmaceuticals market value forecast: $ billion, 2015-20
  • Table 215: United States size of population (million), 2011-15
  • Table 216: United States gdp (constant 2005 prices, $ billion), 2011-15
  • Table 217: United States gdp (current prices, $ billion), 2011-15
  • Table 218: United States inflation, 2011-15
  • Table 219: United States consumer price index (absolute), 2011-15
  • Table 220: United States exchange rate, 2011-15
  • Table 221: Johnson & Johnson: key facts
  • Table 222: Johnson & Johnson: key financials ($)
  • Table 223: Johnson & Johnson: key financial ratios
  • Table 224: Novartis AG: key facts
  • Table 225: Novartis AG: key financials ($)
  • Table 226: Novartis AG: key financial ratios
  • Table 227: Pfizer Inc.: key facts
  • Table 228: Pfizer Inc.: key financials ($)
  • Table 229: Pfizer Inc.: key financial ratios
  • Table 230: F. Hoffmann-La Roche Ltd: key facts
  • Table 231: F. Hoffmann-La Roche Ltd: key financials ($)
  • Table 232: F. Hoffmann-La Roche Ltd: key financials (CHF)
  • Table 233: F. Hoffmann-La Roche Ltd: key financial ratios
  • Table 234: Daiichi Sankyo Co., Ltd.: key facts
  • Table 235: Daiichi Sankyo Co., Ltd.: key financials ($)
  • Table 236: Daiichi Sankyo Co., Ltd.: key financials (¥)
  • Table 237: Daiichi Sankyo Co., Ltd.: key financial ratios
  • Table 238: Dr. Reddy's Laboratories Limited: key facts
  • Table 239: Dr. Reddy's Laboratories Limited: key financials ($)
  • Table 240: Dr. Reddy's Laboratories Limited: key financials (Rs.)
  • Table 241: Dr. Reddy's Laboratories Limited: key financial ratios
  • Table 242: Shanghai Pharmaceuticals Holding Co Ltd: key facts
  • Table 243: Yangtze River Pharmaceutical Group: key facts
  • Table 244: Sanofi SA: key facts
  • Table 245: Sanofi SA: key financials ($)
  • Table 246: Sanofi SA: key financials (€)
  • Table 247: Sanofi SA: key financial ratios
  • Table 248: AstraZeneca PLC: key facts
  • Table 249: AstraZeneca PLC: key financials ($)
  • Table 250: AstraZeneca PLC: key financial ratios
  • Table 251: Laboratoires Pierre Fabre SA: key facts
  • Table 252: Les Laboratoires Servier: key facts
  • Table 253: Bayer AG: key facts
  • Table 254: Bayer AG: key financials ($)
  • Table 255: Bayer AG: key financials (€)
  • Table 256: Bayer AG: key financial ratios
  • Table 257: Boehringer Ingelheim GmbH: key facts
  • Table 258: Boehringer Ingelheim GmbH: key financials ($)
  • Table 259: Boehringer Ingelheim GmbH: key financials (€)
  • Table 260: Boehringer Ingelheim GmbH: key financial ratios
  • Table 261: GlaxoSmithKline Plc: key facts
  • Table 262: GlaxoSmithKline Plc: key financials ($)
  • Table 263: GlaxoSmithKline Plc: key financials (£)
  • Table 264: GlaxoSmithKline Plc: key financial ratios
  • Table 265: Aspen Pharmacare Holdings Ltd: key facts
  • Table 266: Aspen Pharmacare Holdings Ltd: key financials ($)
  • Table 267: Aspen Pharmacare Holdings Ltd: key financials (ZAR)
  • Table 268: Aspen Pharmacare Holdings Ltd: key financial ratios
  • Table 269: Ache Laboratorios Farmaceuticos S.A.: key facts
  • Table 270: EMS Sigma Pharma: key facts
  • Table 271: Apotex, Inc.: key facts
  • Table 272: Merck & Co., Inc.: key facts
  • Table 273: Merck & Co., Inc.: key financials ($)
  • Table 274: Merck & Co., Inc.: key financial ratios
  • Table 275: Guangzhou Pharmaceutical Holdings Limited: key facts
  • Table 276: Yunnan Baiyao Group Co., Ltd.: key facts
  • Table 277: Yunnan Baiyao Group Co., Ltd.: key financials ($)
  • Table 278: Yunnan Baiyao Group Co., Ltd.: key financials (CNY)
  • Table 279: Yunnan Baiyao Group Co., Ltd.: key financial ratios
  • Table 280: Aurobindo Pharma Limited: key facts
  • Table 281: Aurobindo Pharma Limited: key financials ($)
  • Table 282: Aurobindo Pharma Limited: key financials (Rs.)
  • Table 283: Aurobindo Pharma Limited: key financial ratios
  • Table 284: Lupin Limited: key facts
  • Table 285: Lupin Limited: key financials ($)
  • Table 286: Lupin Limited: key financials (Rs.)
  • Table 287: Lupin Limited: key financial ratios
  • Table 288: Sun Pharmaceutical Industries Ltd.: key facts
  • Table 289: Sun Pharmaceutical Industries Ltd.: key financials ($)
  • Table 290: Sun Pharmaceutical Industries Ltd.: key financials (Rs.)
  • Table 291: Sun Pharmaceutical Industries Ltd.: key financial ratios
  • Table 292: PT Kalbe Farma Tbk: key facts
  • Table 293: PT Kalbe Farma Tbk: key financials ($)
  • Table 294: PT Kalbe Farma Tbk: key financials (Rs.)
  • Table 295: PT Kalbe Farma Tbk: key financial ratios
  • Table 296: Chiesi Farmaceutici S.p.A.: key facts
  • Table 297: The Menarini Group: key facts
  • Table 298: Recordati S.p.A.: key facts
  • Table 299: Astellas Pharma GmbH: key facts
  • Table 300: Astellas Pharma GmbH: key financials ($)
  • Table 301: Astellas Pharma GmbH: key financials (¥)
  • Table 302: Astellas Pharma GmbH: key financial ratios
  • Table 303: Takeda Pharmaceutical Company Limited: key facts
  • Table 304: Takeda Pharmaceutical Company Limited: key financials ($)
  • Table 305: Takeda Pharmaceutical Company Limited: key financials (¥)
  • Table 306: Takeda Pharmaceutical Company Limited: key financial ratios
  • Table 307: Adcock Ingram Holdings Limited: key facts
  • Table 308: Adcock Ingram Holdings Limited: key financials ($)
  • Table 309: Adcock Ingram Holdings Limited: key financials (ZAR)
  • Table 310: Adcock Ingram Holdings Limited: key financial ratios
  • Table 311: CKD Bio Corporation: key facts
  • Table 312: Daewoong Pharmaceutical Co., Ltd.: key facts
  • Table 313: Daewoong Pharmaceutical Co., Ltd.: key financials ($)
  • Table 314: Daewoong Pharmaceutical Co., Ltd.: key financials (KRW)
  • Table 315: Daewoong Pharmaceutical Co., Ltd.: key financial ratios
  • Table 316: Hanmi Science Co., Ltd.: key facts
  • Table 317: Almirall S.A.: key facts
  • Table 318: Almirall S.A.: key financials ($)
  • Table 319: Almirall S.A.: key financials (€)
  • Table 320: Almirall S.A.: key financial ratios
  • Table 321: Abdi Ibrahim: key facts

List of Figures

  • Figure 1: Global pharmaceuticals market value: $ billion, 2011-15
  • Figure 2: Global pharmaceuticals market geography segmentation: % share, by value, 2015
  • Figure 3: Global pharmaceuticals market share: % share, by value, 2015
  • Figure 4: Global pharmaceuticals market value forecast: $ billion, 2015-20
  • Figure 5: Forces driving competition in the global pharmaceuticals market, 2015
  • Figure 6: Drivers of buyer power in the global pharmaceuticals market, 2015
  • Figure 7: Drivers of supplier power in the global pharmaceuticals market, 2015
  • Figure 8: Factors influencing the likelihood of new entrants in the global pharmaceuticals market, 2015
  • Figure 9: Factors influencing the threat of substitutes in the global pharmaceuticals market, 2015
  • Figure 10: Drivers of degree of rivalry in the global pharmaceuticals market, 2015
  • Figure 11: Asia-Pacific pharmaceuticals market value: $ billion, 2011-15
  • Figure 12: Asia-Pacific pharmaceuticals market geography segmentation: % share, by value, 2015
  • Figure 13: Asia-Pacific pharmaceuticals market share: % share, by value, 2015
  • Figure 14: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2015-20
  • Figure 15: Forces driving competition in the pharmaceuticals market in Asia-Pacific, 2015
  • Figure 16: Drivers of buyer power in the pharmaceuticals market in Asia-Pacific, 2015
  • Figure 17: Drivers of supplier power in the pharmaceuticals market in Asia-Pacific, 2015
  • Figure 18: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Asia-Pacific, 2015
  • Figure 19: Factors influencing the threat of substitutes in the pharmaceuticals market in Asia-Pacific, 2015
  • Figure 20: Drivers of degree of rivalry in the pharmaceuticals market in Asia-Pacific, 2015
  • Figure 21: Europe pharmaceuticals market value: $ billion, 2011-15
  • Figure 22: Europe pharmaceuticals market geography segmentation: % share, by value, 2015
  • Figure 23: Europe pharmaceuticals market share: % share, by value, 2015
  • Figure 24: Europe pharmaceuticals market value forecast: $ billion, 2015-20
  • Figure 25: Forces driving competition in the pharmaceuticals market in Europe, 2015
  • Figure 26: Drivers of buyer power in the pharmaceuticals market in Europe, 2015
  • Figure 27: Drivers of supplier power in the pharmaceuticals market in Europe, 2015
  • Figure 28: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Europe, 2015
  • Figure 29: Factors influencing the threat of substitutes in the pharmaceuticals market in Europe, 2015
  • Figure 30: Drivers of degree of rivalry in the pharmaceuticals market in Europe, 2015
  • Figure 31: France pharmaceuticals market value: $ billion, 2011-15
  • Figure 32: France pharmaceuticals market geography segmentation: % share, by value, 2015
  • Figure 33: France pharmaceuticals market share: % share, by value, 2015
  • Figure 34: France pharmaceuticals market value forecast: $ billion, 2015-20
  • Figure 35: Forces driving competition in the pharmaceuticals market in France, 2015
  • Figure 36: Drivers of buyer power in the pharmaceuticals market in France, 2015
  • Figure 37: Drivers of supplier power in the pharmaceuticals market in France, 2015
  • Figure 38: Factors influencing the likelihood of new entrants in the pharmaceuticals market in France, 2015
  • Figure 39: Factors influencing the threat of substitutes in the pharmaceuticals market in France, 2015
  • Figure 40: Drivers of degree of rivalry in the pharmaceuticals market in France, 2015
  • Figure 41: Germany pharmaceuticals market value: $ billion, 2011-15
  • Figure 42: Germany pharmaceuticals market geography segmentation: % share, by value, 2015
  • Figure 43: Germany pharmaceuticals market share: % share, by value, 2015
  • Figure 44: Germany pharmaceuticals market value forecast: $ billion, 2015-20
  • Figure 45: Forces driving competition in the pharmaceuticals market in Germany, 2015
  • Figure 46: Drivers of buyer power in the pharmaceuticals market in Germany, 2015
  • Figure 47: Drivers of supplier power in the pharmaceuticals market in Germany, 2015
  • Figure 48: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Germany, 2015
  • Figure 49: Factors influencing the threat of substitutes in the pharmaceuticals market in Germany, 2015
  • Figure 50: Drivers of degree of rivalry in the pharmaceuticals market in Germany, 2015
  • Figure 51: Australia pharmaceuticals market value: $ billion, 2011-15
  • Figure 52: Australia pharmaceuticals market geography segmentation: % share, by value, 2015
  • Figure 53: Australia pharmaceuticals market share: % share, by value, 2015
  • Figure 54: Australia pharmaceuticals market value forecast: $ billion, 2015-20
  • Figure 55: Forces driving competition in the pharmaceuticals market in Australia, 2015
  • Figure 56: Drivers of buyer power in the pharmaceuticals market in Australia, 2015
  • Figure 57: Drivers of supplier power in the pharmaceuticals market in Australia, 2015
  • Figure 58: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Australia, 2015
  • Figure 59: Factors influencing the threat of substitutes in the pharmaceuticals market in Australia, 2015
  • Figure 60: Drivers of degree of rivalry in the pharmaceuticals market in Australia, 2015
  • Figure 61: Brazil pharmaceuticals market value: $ billion, 2011-15
  • Figure 62: Brazil pharmaceuticals market geography segmentation: % share, by value, 2015
  • Figure 63: Brazil pharmaceuticals market share: % share, by value, 2015
  • Figure 64: Brazil pharmaceuticals market value forecast: $ billion, 2015-20
  • Figure 65: Forces driving competition in the pharmaceuticals market in Brazil, 2015
  • Figure 66: Drivers of buyer power in the pharmaceuticals market in Brazil, 2015
  • Figure 67: Drivers of supplier power in the pharmaceuticals market in Brazil, 2015
  • Figure 68: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Brazil, 2015
  • Figure 69: Factors influencing the threat of substitutes in the pharmaceuticals market in Brazil, 2015
  • Figure 70: Drivers of degree of rivalry in the pharmaceuticals market in Brazil, 2015
  • Figure 71: Canada pharmaceuticals market value: $ billion, 2011-15
  • Figure 72: Canada pharmaceuticals market geography segmentation: % share, by value, 2015
  • Figure 73: Canada pharmaceuticals market share: % share, by value, 2015
  • Figure 74: Canada pharmaceuticals market value forecast: $ billion, 2015-20
  • Figure 75: Forces driving competition in the pharmaceuticals market in Canada, 2015
  • Figure 76: Drivers of buyer power in the pharmaceuticals market in Canada, 2015
  • Figure 77: Drivers of supplier power in the pharmaceuticals market in Canada, 2015
  • Figure 78: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Canada, 2015
  • Figure 79: Factors influencing the threat of substitutes in the pharmaceuticals market in Canada, 2015
  • Figure 80: Drivers of degree of rivalry in the pharmaceuticals market in Canada, 2015
  • Figure 81: China pharmaceuticals market value: $ billion, 2011-15
  • Figure 82: China pharmaceuticals market geography segmentation: % share, by value, 2015
  • Figure 83: China pharmaceuticals market share: % share, by value, 2015
  • Figure 84: China pharmaceuticals market value forecast: $ billion, 2015-20
  • Figure 85: Forces driving competition in the pharmaceuticals market in China, 2015
  • Figure 86: Drivers of buyer power in the pharmaceuticals market in China, 2015
  • Figure 87: Drivers of supplier power in the pharmaceuticals market in China, 2015
  • Figure 88: Factors influencing the likelihood of new entrants in the pharmaceuticals market in China, 2015
  • Figure 89: Factors influencing the threat of substitutes in the pharmaceuticals market in China, 2015
  • Figure 90: Drivers of degree of rivalry in the pharmaceuticals market in China, 2015
  • Figure 91: India pharmaceuticals market value: $ billion, 2011-15
  • Figure 92: India pharmaceuticals market geography segmentation: % share, by value, 2015
  • Figure 93: India pharmaceuticals market share: % share, by value, 2015
  • Figure 94: India pharmaceuticals market value forecast: $ billion, 2015-20
  • Figure 95: Forces driving competition in the pharmaceuticals market in India, 2015
  • Figure 96: Drivers of buyer power in the pharmaceuticals market in India, 2015
  • Figure 97: Drivers of supplier power in the pharmaceuticals market in India, 2015
  • Figure 98: Factors influencing the likelihood of new entrants in the pharmaceuticals market in India, 2015
  • Figure 99: Factors influencing the threat of substitutes in the pharmaceuticals market in India, 2015
  • Figure 100: Drivers of degree of rivalry in the pharmaceuticals market in India, 2015
  • Figure 101: Indonesia pharmaceuticals market value: $ billion, 2011-15
  • Figure 102: Indonesia pharmaceuticals market geography segmentation: % share, by value, 2015
  • Figure 103: Indonesia pharmaceuticals market share: % share, by value, 2015
  • Figure 104: Indonesia pharmaceuticals market value forecast: $ billion, 2015-20
  • Figure 105: Forces driving competition in the pharmaceuticals market in Indonesia, 2015
  • Figure 106: Drivers of buyer power in the pharmaceuticals market in Indonesia, 2015
  • Figure 107: Drivers of supplier power in the pharmaceuticals market in Indonesia, 2015
  • Figure 108: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Indonesia, 2015
  • Figure 109: Factors influencing the threat of substitutes in the pharmaceuticals market in Indonesia, 2015
  • Figure 110: Drivers of degree of rivalry in the pharmaceuticals market in Indonesia, 2015
  • Figure 111: Italy pharmaceuticals market value: $ billion, 2011-15
  • Figure 112: Italy pharmaceuticals market geography segmentation: % share, by value, 2015
  • Figure 113: Italy pharmaceuticals market share: % share, by value, 2015
  • Figure 114: Italy pharmaceuticals market value forecast: $ billion, 2015-20
  • Figure 115: Forces driving competition in the pharmaceuticals market in Italy, 2015
  • Figure 116: Drivers of buyer power in the pharmaceuticals market in Italy, 2015
  • Figure 117: Drivers of supplier power in the pharmaceuticals market in Italy, 2015
  • Figure 118: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Italy, 2015
  • Figure 119: Factors influencing the threat of substitutes in the pharmaceuticals market in Italy, 2015
  • Figure 120: Drivers of degree of rivalry in the pharmaceuticals market in Italy, 2015
  • Figure 121: Japan pharmaceuticals market value: $ billion, 2011-15
  • Figure 122: Japan pharmaceuticals market geography segmentation: % share, by value, 2015
  • Figure 123: Japan pharmaceuticals market share: % share, by value, 2015
  • Figure 124: Japan pharmaceuticals market value forecast: $ billion, 2015-20
  • Figure 125: Forces driving competition in the pharmaceuticals market in Japan, 2015
  • Figure 126: Drivers of buyer power in the pharmaceuticals market in Japan, 2015
  • Figure 127: Drivers of supplier power in the pharmaceuticals market in Japan, 2015
  • Figure 128: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Japan, 2015
  • Figure 129: Factors influencing the threat of substitutes in the pharmaceuticals market in Japan, 2015
  • Figure 130: Drivers of degree of rivalry in the pharmaceuticals market in Japan, 2015
  • Figure 131: Mexico pharmaceuticals market value: $ billion, 2011-15
  • Figure 132: Mexico pharmaceuticals market geography segmentation: % share, by value, 2015
  • Figure 133: Mexico pharmaceuticals market share: % share, by value, 2015
  • Figure 134: Mexico pharmaceuticals market value forecast: $ billion, 2015-20
  • Figure 135: Forces driving competition in the pharmaceuticals market in Mexico, 2015
  • Figure 136: Drivers of buyer power in the pharmaceuticals market in Mexico, 2015
  • Figure 137: Drivers of supplier power in the pharmaceuticals market in Mexico, 2015
  • Figure 138: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Mexico, 2015
  • Figure 139: Factors influencing the threat of substitutes in the pharmaceuticals market in Mexico, 2015
  • Figure 140: Drivers of degree of rivalry in the pharmaceuticals market in Mexico, 2015
  • Figure 141: Netherlands pharmaceuticals market value: $ billion, 2011-15
  • Figure 142: Netherlands pharmaceuticals market geography segmentation: % share, by value, 2015
  • Figure 143: Netherlands pharmaceuticals market share: % share, by value, 2015
  • Figure 144: Netherlands pharmaceuticals market value forecast: $ billion, 2015-20
  • Figure 145: Forces driving competition in the pharmaceuticals market in the Netherlands, 2015
  • Figure 146: Drivers of buyer power in the pharmaceuticals market in the Netherlands, 2015
  • Figure 147: Drivers of supplier power in the pharmaceuticals market in the Netherlands, 2015
  • Figure 148: Factors influencing the likelihood of new entrants in the pharmaceuticals market in the Netherlands, 2015
  • Figure 149: Factors influencing the threat of substitutes in the pharmaceuticals market in the Netherlands, 2015
  • Figure 150: Drivers of degree of rivalry in the pharmaceuticals market in the Netherlands, 2015
  • Figure 151: North America pharmaceuticals market value: $ billion, 2011-15
  • Figure 152: North America pharmaceuticals market geography segmentation: % share, by value, 2015
  • Figure 153: North America pharmaceuticals market share: % share, by value, 2015
  • Figure 154: North America pharmaceuticals market value forecast: $ billion, 2015-20
  • Figure 155: Forces driving competition in the pharmaceuticals market in North America, 2015
  • Figure 156: Drivers of buyer power in the pharmaceuticals market in North America, 2015
  • Figure 157: Drivers of supplier power in the pharmaceuticals market in North America, 2015
  • Figure 158: Factors influencing the likelihood of new entrants in the pharmaceuticals market in North America, 2015
  • Figure 159: Factors influencing the threat of substitutes in the pharmaceuticals market in North America, 2015
  • Figure 160: Drivers of degree of rivalry in the pharmaceuticals market in North America, 2015
  • Figure 161: Russia pharmaceuticals market value: $ billion, 2011-15
  • Figure 162: Russia pharmaceuticals market geography segmentation: % share, by value, 2015
  • Figure 163: Russia pharmaceuticals market share: % share, by value, 2015
  • Figure 164: Russia pharmaceuticals market value forecast: $ billion, 2015-20
  • Figure 165: Forces driving competition in the pharmaceuticals market in Russia, 2015
  • Figure 166: Drivers of buyer power in the pharmaceuticals market in Russia, 2015
  • Figure 167: Drivers of supplier power in the pharmaceuticals market in Russia, 2015
  • Figure 168: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Russia, 2015
  • Figure 169: Factors influencing the threat of substitutes in the pharmaceuticals market in Russia, 2015
  • Figure 170: Drivers of degree of rivalry in the pharmaceuticals market in Russia, 2015
  • Figure 171: Scandinavia pharmaceuticals market value: $ billion, 2011-15
  • Figure 172: Scandinavia pharmaceuticals market geography segmentation: % share, by value, 2015
  • Figure 173: Scandinavia pharmaceuticals market share: % share, by value, 2015
  • Figure 174: Scandinavia pharmaceuticals market value forecast: $ billion, 2015-20
  • Figure 175: Forces driving competition in the pharmaceuticals market in Scandinavia, 2015
  • Figure 176: Drivers of buyer power in the pharmaceuticals market in Scandinavia, 2015
  • Figure 177: Drivers of supplier power in the pharmaceuticals market in Scandinavia, 2015
  • Figure 178: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Scandinavia, 2015
  • Figure 179: Factors influencing the threat of substitutes in the pharmaceuticals market in Scandinavia, 2015
  • Figure 180: Drivers of degree of rivalry in the pharmaceuticals market in Scandinavia, 2015
  • Figure 181: Singapore pharmaceuticals market value: $ billion, 2011-15
  • Figure 182: Singapore pharmaceuticals market geography segmentation: % share, by value, 2015
  • Figure 183: Singapore pharmaceuticals market share: % share, by value, 2015
  • Figure 184: Singapore pharmaceuticals market value forecast: $ billion, 2015-20
  • Figure 185: Forces driving competition in the pharmaceuticals market in Singapore, 2015
  • Figure 186: Drivers of buyer power in the pharmaceuticals market in Singapore, 2015
  • Figure 187: Drivers of supplier power in the pharmaceuticals market in Singapore, 2015
  • Figure 188: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Singapore, 2015
  • Figure 189: Factors influencing the threat of substitutes in the pharmaceuticals market in Singapore, 2015
  • Figure 190: Drivers of degree of rivalry in the pharmaceuticals market in Singapore, 2015
  • Figure 191: South Africa pharmaceuticals market value: $ billion, 2011-15
  • Figure 192: South Africa pharmaceuticals market geography segmentation: % share, by value, 2015
  • Figure 193: South Africa pharmaceuticals market share: % share, by value, 2015
  • Figure 194: South Africa pharmaceuticals market value forecast: $ billion, 2015-20
  • Figure 195: Forces driving competition in the pharmaceuticals market in South Africa, 2015
  • Figure 196: Drivers of buyer power in the pharmaceuticals market in South Africa, 2015
  • Figure 197: Drivers of supplier power in the pharmaceuticals market in South Africa, 2015
  • Figure 198: Factors influencing the likelihood of new entrants in the pharmaceuticals market in South Africa, 2015
  • Figure 199: Factors influencing the threat of substitutes in the pharmaceuticals market in South Africa, 2015
  • Figure 200: Drivers of degree of rivalry in the pharmaceuticals market in South Africa, 2015
  • Figure 201: South Korea pharmaceuticals market value: $ billion, 2011-15
  • Figure 202: South Korea pharmaceuticals market geography segmentation: % share, by value, 2015
  • Figure 203: South Korea pharmaceuticals market share: % share, by value, 2015
  • Figure 204: South Korea pharmaceuticals market value forecast: $ billion, 2015-20
  • Figure 205: Forces driving competition in the pharmaceuticals market in South Korea, 2015
  • Figure 206: Drivers of buyer power in the pharmaceuticals market in South Korea, 2015
  • Figure 207: Drivers of supplier power in the pharmaceuticals market in South Korea, 2015
  • Figure 208: Factors influencing the likelihood of new entrants in the pharmaceuticals market in South Korea, 2015
  • Figure 209: Factors influencing the threat of substitutes in the pharmaceuticals market in South Korea, 2015
  • Figure 210: Drivers of degree of rivalry in the pharmaceuticals market in South Korea, 2015
  • Figure 211: Spain pharmaceuticals market value: $ billion, 2011-15
  • Figure 212: Spain pharmaceuticals market geography segmentation: % share, by value, 2015
  • Figure 213: Spain pharmaceuticals market share: % share, by value, 2015
  • Figure 214: Spain pharmaceuticals market value forecast: $ billion, 2015-20
  • Figure 215: Forces driving competition in the pharmaceuticals market in Spain, 2015
  • Figure 216: Drivers of buyer power in the pharmaceuticals market in Spain, 2015
  • Figure 217: Drivers of supplier power in the pharmaceuticals market in Spain, 2015
  • Figure 218: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Spain, 2015
  • Figure 219: Factors influencing the threat of substitutes in the pharmaceuticals market in Spain, 2015
  • Figure 220: Drivers of degree of rivalry in the pharmaceuticals market in Spain, 2015
  • Figure 221: Turkey pharmaceuticals market value: $ billion, 2011-15
  • Figure 222: Turkey pharmaceuticals market geography segmentation: % share, by value, 2015
  • Figure 223: Turkey pharmaceuticals market share: % share, by value, 2015
  • Figure 224: Turkey pharmaceuticals market value forecast: $ billion, 2015-20
  • Figure 225: Forces driving competition in the pharmaceuticals market in Turkey, 2015
  • Figure 226: Drivers of buyer power in the pharmaceuticals market in Turkey, 2015
  • Figure 227: Drivers of supplier power in the pharmaceuticals market in Turkey, 2015
  • Figure 228: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Turkey, 2015
  • Figure 229: Factors influencing the threat of substitutes in the pharmaceuticals market in Turkey, 2015
  • Figure 230: Drivers of degree of rivalry in the pharmaceuticals market in Turkey, 2015
  • Figure 231: United Kingdom pharmaceuticals market value: $ billion, 2011-15
  • Figure 232: United Kingdom pharmaceuticals market geography segmentation: % share, by value, 2015
  • Figure 233: United Kingdom pharmaceuticals market share: % share, by value, 2015
  • Figure 234: United Kingdom pharmaceuticals market value forecast: $ billion, 2015-20
  • Figure 235: Forces driving competition in the pharmaceuticals market in the United Kingdom, 2015
  • Figure 236: Drivers of buyer power in the pharmaceuticals market in the United Kingdom, 2015
  • Figure 237: Drivers of supplier power in the pharmaceuticals market in the United Kingdom, 2015
  • Figure 238: Factors influencing the likelihood of new entrants in the pharmaceuticals market in the United Kingdom, 2015
  • Figure 239: Factors influencing the threat of substitutes in the pharmaceuticals market in the United Kingdom, 2015
  • Figure 240: Drivers of degree of rivalry in the pharmaceuticals market in the United Kingdom, 2015
  • Figure 241: United States pharmaceuticals market value: $ billion, 2011-15
  • Figure 242: United States pharmaceuticals market geography segmentation: % share, by value, 2015
  • Figure 243: United States pharmaceuticals market share: % share, by value, 2015
  • Figure 244: United States pharmaceuticals market value forecast: $ billion, 2015-20
  • Figure 245: Forces driving competition in the pharmaceuticals market in the United States, 2015
  • Figure 246: Drivers of buyer power in the pharmaceuticals market in the United States, 2015
  • Figure 247: Drivers of supplier power in the pharmaceuticals market in the United States, 2015
  • Figure 248: Factors influencing the likelihood of new entrants in the pharmaceuticals market in the United States, 2015
  • Figure 249: Factors influencing the threat of substitutes in the pharmaceuticals market in the United States, 2015
  • Figure 250: Drivers of degree of rivalry in the pharmaceuticals market in the United States, 2015
  • Figure 251: Johnson & Johnson: revenues & profitability
  • Figure 252: Johnson & Johnson: assets & liabilities
  • Figure 253: Novartis AG: revenues & profitability
  • Figure 254: Novartis AG: assets & liabilities
  • Figure 255: Pfizer Inc.: revenues & profitability
  • Figure 256: Pfizer Inc.: assets & liabilities
  • Figure 257: F. Hoffmann-La Roche Ltd: revenues & profitability
  • Figure 258: F. Hoffmann-La Roche Ltd: assets & liabilities
  • Figure 259: Daiichi Sankyo Co., Ltd.: revenues & profitability
  • Figure 260: Daiichi Sankyo Co., Ltd.: assets & liabilities
  • Figure 261: Dr. Reddy's Laboratories Limited: revenues & profitability
  • Figure 262: Dr. Reddy's Laboratories Limited: assets & liabilities
  • Figure 263: Sanofi SA: revenues & profitability
  • Figure 264: Sanofi SA: assets & liabilities
  • Figure 265: AstraZeneca PLC: revenues & profitability
  • Figure 266: AstraZeneca PLC: assets & liabilities
  • Figure 267: Bayer AG: revenues & profitability
  • Figure 268: Bayer AG: assets & liabilities
  • Figure 269: Boehringer Ingelheim GmbH: revenues & profitability
  • Figure 270: Boehringer Ingelheim GmbH: assets & liabilities
  • Figure 271: GlaxoSmithKline Plc: revenues & profitability
  • Figure 272: GlaxoSmithKline Plc: assets & liabilities
  • Figure 273: Aspen Pharmacare Holdings Ltd: revenues & profitability
  • Figure 274: Aspen Pharmacare Holdings Ltd: assets & liabilities
  • Figure 275: Merck & Co., Inc.: revenues & profitability
  • Figure 276: Merck & Co., Inc.: assets & liabilities
  • Figure 277: Yunnan Baiyao Group Co., Ltd.: revenues & profitability
  • Figure 278: Yunnan Baiyao Group Co., Ltd.: assets & liabilities
  • Figure 279: Aurobindo Pharma Limited: revenues & profitability
  • Figure 280: Aurobindo Pharma Limited: assets & liabilities
  • Figure 281: Lupin Limited: revenues & profitability
  • Figure 282: Lupin Limited: assets & liabilities
  • Figure 283: Sun Pharmaceutical Industries Ltd.: revenues & profitability
  • Figure 284: Sun Pharmaceutical Industries Ltd.: assets & liabilities
  • Figure 285: PT Kalbe Farma Tbk: revenues & profitability
  • Figure 286: PT Kalbe Farma Tbk: assets & liabilities
  • Figure 287: Astellas Pharma GmbH: revenues & profitability
  • Figure 288: Astellas Pharma GmbH: assets & liabilities
  • Figure 289: Takeda Pharmaceutical Company Limited: revenues & profitability
  • Figure 290: Takeda Pharmaceutical Company Limited: assets & liabilities
  • Figure 291: Adcock Ingram Holdings Limited: revenues & profitability
  • Figure 292: Adcock Ingram Holdings Limited: assets & liabilities
  • Figure 293: Daewoong Pharmaceutical Co., Ltd.: revenues & profitability
  • Figure 294: Daewoong Pharmaceutical Co., Ltd.: assets & liabilities
  • Figure 295: Almirall S.A.: revenues & profitability
Back to Top